Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune diseaseRené Pfeifle, Gerhard Krönke|Nature Immunology|2016Cited by 311
12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in ArthritisGerhard Krönke, Georg Schett|The Journal of Immunology|2009Cited by 163
Bispecific T cell engager therapy for refractory rheumatoid arthritisLaura Bucci, Ricardo Grieshaber‐Bouyer, Melanie Hagen et al.|Nature Medicine|2024Cited by 147
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trialJürgen Rech, Georg Schett, Arnd Kleyer et al.|The Lancet|2024Cited by 134
Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugsDavid Simón, Asmir Vodenčarević, Koray Taşçılar et al.|Arthritis Research & Therapy|2021Cited by 60